Skip to content

Retrospective analysis study on the prognosis of patients with resectable pancreatic neuroendocrine tumors

Retrospective analysis study on the prognosis of patients with resectable pancreatic neuroendocrine tumors - Retrospective analysis of patients with resectable pancreatic neuroendocrine tumors

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000013335
Enrollment
40
Registered
2014-05-01
Start date
2014-03-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic neuroendocrine tumor

Interventions

None listed

Sponsors

Kyoto University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patients with resected pancreatic neuroendocrine tumors

Exclusion criteria

Exclusion criteria: unresectable cases

Design outcomes

Primary

MeasureTime frame
Compare the enhancement pattern of CECT and their malignant potential from pathological findings

Secondary

MeasureTime frame
1) Compare the enhancement pattern of CECT and detailed pathological findings 2) Relation between the enhancement pattern of CECT and prognosis

Countries

Japan

Contacts

Public ContactAkira Kurita

Kyoto University Department of Gastroenterology and Hepatology

akurita@kuhp.kyoto-u.ac.jp075-751-4319

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026